Gluskin Sheff & Assoc Inc Astrazeneca PLC Transaction History
Gluskin Sheff & Assoc Inc
- $832 Million
- Q2 2024
A detailed history of Gluskin Sheff & Assoc Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 32,840 shares of AZN stock, worth $2.61 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
32,840
Previous 29,840
10.05%
Holding current value
$2.61 Million
Previous $2.02 Million
26.72%
% of portfolio
0.31%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.17 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.39 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.23 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.92 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.4 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $247B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...